嘌呤代谢与肌张力障碍:一个长期被寄予厚望的关系
本文综述了支持嘌呤代谢异常与肌张力障碍发病机制相交织的证据。近期发现的 IMPDH2 相关肌张力障碍在嘌呤能系统缺陷中引入了功能获得性范式,为理解脑疾病中的嘌呤池失衡提供了新视角。作者讨论了已知肌张力障碍相关机制与嘌呤代谢障碍(包括 Lesch-Nyhan 病)研究新出现的机制之间的共性,并假设更深入认识嘌呤扰动与肌张力障碍的相关性可提供新的治疗干预途径。
要点
- 嘌呤代谢异常与肌张力障碍发病机制存在交叉。
- IMPDH2 相关肌张力障碍提示嘌呤能系统缺陷可为功能获得性机制。
- 嘌呤代谢障碍(如 Lesch-Nyhan 病)机制与已知肌张力障碍机制有共性。
核心结论
- 嘌呤代谢异常与肌张力障碍发病机制相交织,更深入认识嘌呤扰动可能提供新的治疗干预途径。
研究设计与样本
- 综述,总结支持嘌呤代谢异常与肌张力障碍发病机制相交织的证据,并讨论已知肌张力障碍相关机制与嘌呤代谢障碍研究新出现机制的共性。
主要发现
- 近期发现的 IMPDH2 相关肌张力障碍在嘌呤能系统缺陷中引入了功能获得性范式,为理解脑疾病中的嘌呤池失衡提供了新视角。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dystonia research focuses on the identification of converging biological pathways, allowing to define molecular drivers that serve as treatment targets. We summarize evidence supporting the concept that aberrations in purine metabolism intersect with dystonia pathogenesis. The recent discovery of IMPDH2-related dystonia introduced a gain-of-function paradigm in purinergic system defects, offering new perspectives to understand purine-pool imbalances in brain diseases. We discuss commonalities between known dystonia-linked mechanisms and mechanisms emerging from studies of purine metabolism disorders including Lesch-Nyhan disease. Together, we hypothesize that a greater appreciation of the relevance of purine perturbances in dystonia can offer fresh avenues for therapeutic intervention. ANN NEUROL 2025;97:809-825.
引用
- Sorrentino U, O'Neill AG, Kollman JM, et al. Purine Metabolism and Dystonia: Perspectives of a Long-Promised Relationship. Ann Neurol. 2025. PMID: 40026236. doi:10.1002/ana.27227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。